RCB1229

Risk Reward, Plenty of Potential vs Problems

Long
NASDAQ:MYGN   Myriad Genetics, Inc
MYGN has been a player for a while, large company, with actual earnings , however litigation and companies are generally a bad thing. "healthy" enough of a chart for me to participate, but I will not have much patience to the downside, stop in place.

**Long this last collapse, limited in size... confidence is enough to buy, not enough to bet the farm
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.